Showing 2031-2040 of 2314 results for "".
- AstraZeneca Says COVID-19 Vaccine Candidate Shows 70% Efficacyhttps://modernod.com/news/astrazeneca-says-covid-19-vaccine-candidate-shows-70-efficacy/2478588/AstraZeneca announced that a combined interim analysis of late-stage studies showed that the COVID-19 candidate vaccine AZD1222 had an average efficacy of 70%, increasing to 90% for a regimen that included initial immunization with a half dose. The pooled data come from the COV002 phase 2/3 trial
- Amazon Unveils Pharmacy Offering, Hitting Shares of Drug Retailershttps://modernod.com/news/amazon-unveils-pharmacy-offering-hitting-shares-of-drug-retailers/2478569/Amazon.com announced Tuesday the launch of Amazon Pharmacy, allowing customers in the US to complete an entire pharmacy transaction on their desktop or mobile device through the Amazon app. The move sent shares in other drug retailers down, with Walgreens Boots falling over 11%, CVS Health slippi
- Gemini Therapeutics Announces GEM103 Meets All Endpoints in Phase 1 Clinical Studyhttps://modernod.com/news/gemini-therapeutics-announces-gem103-meets-all-endpoints-in-phase-1-clinical-study/2478546/Gemini Therapeutics announced that the phase 1 study of GEM103, the company’s investigational treatment for dry AMD, met all its endpoints. Results demonstrate that in 12 patients receiving a single intravitreal (IVT) injection of GEM103, there were no dose-limiting toxicities or treatment-
- ScienceBased Health Announces Expansion of its Optometry Clinical Advisory Panelhttps://modernod.com/news/sciencebased-health-announces-expansion-of-its-optometry-clinical-advisory-panel/2478537/ScienceBased Health (SBH), a provider of nutraceuticals for eye health, announced the addition of Tracy Doll, OD, FAAO; Scott Hauswirth, OD, FAAO; and Justin Schweitzer, OD, FAAO, to its Clinical Advisory Panel. “We’re honored to welcome these distinguished practitioners to our Clini
- American Academy of Ophthalmology Leads Global Initiative to Address Worldwide Myopia Epidemichttps://modernod.com/news/american-academy-of-ophthalmology-leads-global-initiative-to-address-worldwide-myopia-epidemic/2478535/The number of Americans who are nearsighted has nearly doubled over the last 50 years to about 41.6 percent. This upward trend is evident in nearly every corner of the world, but nowhere near as dramatic as in East and Southeast Asia, where 80 to 90 percent of chi
- Wize Pharma Announces Positive Topline Results in Phase 4 Study of LO2A for Dry Eye in Patients with Sjögren’s Syndromehttps://modernod.com/news/wize-pharma-announces-positive-topline-results-in-phase-4-study-of-lo2a-for-dry-eye-in-patients-with-sjogrens-syndrome/2478529/Wize Pharma reported topline results from its phase 4 clinical trial of its in-license eye drop formula, LO2A, for the symptomatic treatment of dry eye syndrome (DES) in patients with Sjögren’s syndrome. The randomized, double-masked comparative study evaluated LO2A versus Alcon̵
- Russia Says COVID-19 Vaccine Sputnik V 92% Effective in Late-Stage Studyhttps://modernod.com/news/russia-says-covid-19-vaccine-sputnik-v-92-effective-in-late-stage-study/2478524/Interim results from a phase 3 study of the Gamaleya Institute’s COVID-19 vaccine Sputnik V suggest that it had an efficacy rate of 92% after the second dose, the Russian Direct Investment Fund (RDIF) announced Wednesday. The data come after 20 confirmed cases of coronavirus were recorded 2
- Pfizer Goes Solo on U.S. Shot Distribution, Opting Out of Government Channelshttps://modernod.com/news/pfizer-goes-solo-on-u-s-shot-distribution-opting-out-of-government-channels/2478499/Pfizer had already made it quite clear that it doesn’t need the U.S. government to help distribute its COVID-19 vaccine, should it be authorized by the FDA. Now it’s putting an exclamation point on that declaration, according to a FiercePharma
- Aerie Pharmaceuticals Initiates Phase 2b Clinical Trial of AR-15512 for the Treatment of Dry Eye Diseasehttps://modernod.com/news/aerie-pharmaceuticals-initiates-phase-2b-clinical-trial-of-ar-15512-trpm8-agonist-ophthalmic-solution-for-the-treatment-of-patients-with-dry-eye-disease/2478473/Aerie Pharmaceuticals announced the commencement of COMET-1, a phase 2b clinical trial of AR-15512 (TRPM8 agonist) ophthalmic solution for the treatment of patients with dry eye disease. The COMET-1 trial is a randomized, double-masked, vehicle-controlled trial evaluating the efficacy and
- iVeena Announces Positive Topline Results of IVMED-80 Eye Drops for Keratoconushttps://modernod.com/news/iveena-announces-positive-topline-results-of-ivmed-80-eye-drops-for-keratoconus/2478466/iVeena has announced topline results of its recently completed phase 1/2a clinical trial, “A Randomized, Double-Masked, Trial of IVMED-80 Eyedrops for Treatment of Keratoconus.” The study objective was to determine whether a 6- or 16-week course of twice-daily IVMED-80 eyedrops (vs. placebo) coul